Interaction of the novel agent amphethinile with tubulin.

por McGown, A. T., Fox, B. W.
Publicado 1989

Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines.

por McGown, A., Poppitt, D. G., Fox, B. W.
Publicado 1987

Pre-clinical studies of a novel anti-mitotic agent, amphethinile.

por McGown, A. T., Ewen, C., Smith, D. B., Fox, B. W.
Publicado 1988

Metallothionein levels in ovarian tumours before and after chemotherapy.

por Murphy, D., McGown, A. T., Crowther, D., Mander, A., Fox, B. W.
Publicado 1991

Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome.

por Wrigley, E. C., McGown, A. T., Buckley, H., Hall, A., Crowther, D.
Publicado 1996

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

por Grosios, K, Holwell, S E, McGown, A T, Pettit, G R, Bibby, M C
Publicado 1999

Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro

por Booth, C, Hargreaves, D F, Hadfield, J A, McGown, A T, Potten, C S
Publicado 1999

Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy.

por Murphy, D., McGown, A. T., Hall, A., Cattan, A., Crowther, D., Fox, B. W.
Publicado 1992

Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro.

por McGown, A. T., Jayson, G., Pettit, G. R., Haran, M. S., Ward, T. H., Crowther, D.
Publicado 1998

The interaction with tubulin of a series of stilbenes based on combretastatin A-4.

por Woods, J. A., Hadfield, J. A., Pettit, G. R., Fox, B. W., McGown, A. T.
Publicado 1995

Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours

por Cheeseman, S L, Brannan, M, McGown, A, Khan, P, Gardner, C, Gumbrell, L, Dickens, D, Ranson, M
Publicado 2000

Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features.

por Renninson, J., Baker, B. W., McGown, A. T., Murphy, D., Norton, J. D., Fox, B. W., Crowther, D.
Publicado 1994

Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.

por Prendiville, J., McGown, A. T., Gescher, A., Dickson, A. J., Courage, C., Pettit, G. R., Crowther, D., Fox, B. W.
Publicado 1994

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma

por Blackhall, F H, Ranson, M, Radford, J A, Hancock, B W, Soukop, M, McGown, A T, Robbins, A, Halbert, G
Publicado 2001

A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

por Jayson, G. C., Crowther, D., Prendiville, J., McGown, A. T., Scheid, C., Stern, P., Young, R., Brenchley, P., Chang, J., Owens, S.
Publicado 1995

Analogues of Y27632 increase gap junction communication and suppress the formation of transformed NIH3T3 colonies

por Hampson, L, He, X T, Oliver, A W, Hadfield, J A, Kemp, T, Butler, J, McGown, A, Kitchener, H C, Hampson, I N
Publicado 2009

A phase I study of intravenous bryostatin 1 in patients with advanced cancer.

por Prendiville, J., Crowther, D., Thatcher, N., Woll, P. J., Fox, B. W., McGown, A., Testa, N., Stern, P., McDermott, R., Potter, M.
Publicado 1993